The incidence of all-cause mortality and myocardial infarction were higher and marginally significant in participants treated with ARB (RR 1.03, 95% CI 1.00 to 1.06 and 1.04, 95% CI 0.96 to 1.12, respectively).
← all excerpts
Angiotensin receptor blockers for prevention of cardiovascular disease: where does the evidence stand?
1
—
—